2023-507674-41-00已完成1 期
A phase I study of [177Lu]Lu-EVS459 in patients with ovarian and lung cancers
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 58
- 试验地点
- 10
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Novartis Pharma Arzneimittel GmbH
Scientific
Novartis Pharma AG
研究点 (10)
Loading locations...
相似试验
已完成
3 期
Clinical Trial of EPI-743 in Patients with Leigh Syndrome [Extended Treatment Study]eigh SyndromeJPRN-jRCT2080222577Sumitomo Dainippon Pharma Co., Ltd.5
招募中
1 期
Study of LY3537982 in Cancer Patients with a Specific Genetic Mutation (KRAS G12C)SCLCCRCEndometrial NeoplasmsOvarian NeoplasmsPancreatic NeoplasmsBiliary Tract NeoplasmsFrontline, 1L, First LineJPRN-jRCT2031210265Masaki Takeshi80
未知
1 期
A Phase 1 Study of LY2523355 in Patients with Solid CancerJPRN-jRCT2080221457Kyowa Hakko Kirin Co., Ltd.
招募中
2 期
177Lu-PSMA RADIOLIGAND THERAPY IN PATIENTS WITH LYMPH NODE METASTATIC HORMONE-SENSITIVE PROSTATE CANCER UNDERGOING ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTIOprostate cancerNL-OMON52075Vrije Universiteit Medisch Centrum10
招募中
1 期
177Lu-PSMA RADIOLIGAND THERAPY IN PATIENTS WITH LYMPH NODE METASTATIC HORMONE-SENSITIVE PROSTATE CANCER UNDERGOING ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTIOprostate cancer, eligible for radical prostatectomy and extended pelvic lymph node dissection, with 1-3 pelvic nodal metastases on preoperative PSMA PETEUCTR2020-004991-16-NL10